Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Clene Inc. - Common Stock
(NQ:
CLNN
)
6.320
+0.150 (+2.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Clene Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
New Smart Pen Shows 96% Efficacy in Detecting Parkinson’s Disease
September 16, 2025
Via
Investor Brand Network
Clene Inc.’s (NASDAQ: CLNN) Lead Candidate CNM-Au8(R) Shows Promise in Improving Cellular Health in Parkinson’s Disease
September 16, 2025
Via
Investor Brand Network
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Advances Toward NDA Submission for ALS Therapy
September 09, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Presents Preclinical Data Showing CNM-Au8 Improves Cellular Health in Parkinson’s Disease Model
September 04, 2025
Via
Investor Brand Network
Research Uncovers Possible Way to Repair Myelin in MS Patients
September 04, 2025
Via
Investor Brand Network
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at H.C. Wainwright Global Investment Conference
September 02, 2025
Via
Investor Brand Network
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Builds Late-Stage Momentum in Neuro Pipeline
August 29, 2025
Via
Investor Brand Network
Pioneering Therapy Could Slow the Effects of Aging
August 22, 2025
Via
Investor Brand Network
Clene Inc. (NASDAQ: CLNN) Reports Q2 2025 Results as Company Prepares for NDA Submission and Extends Runway into 2026
August 21, 2025
Via
Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 20, 2025
Via
Benzinga
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Reports Q2 2025 Results, Targets Year-End NDA Submission for ALS Therapy
August 14, 2025
Via
Investor Brand Network
Clene Posts 70% Revenue Drop in Q2
August 14, 2025
Via
The Motley Fool
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present Corporate Update at Emerging Growth Conference on Aug. 20
August 13, 2025
Via
Investor Brand Network
Parkinson’s-Gut Bacteria Link Suggests Surprisingly Simple Treatment Option
August 12, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) to Present at Canaccord 45th Annual Growth Conference
August 05, 2025
Via
Investor Brand Network
New AI-Based Speech Tool Detects Possibility of Parkinson’s Disease
July 31, 2025
Via
Investor Brand Network
Clene Inc. (NASDAQ: CLNN) Offers Investors a Compelling Entry into the Growing ALS Market with Key FDA Milestones for Lead Drug Candidate
July 28, 2025
Via
Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Builds Momentum to Bring New Hope to Neuro Patients
July 25, 2025
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
July 18, 2025
Via
Benzinga
Individuals Who Develop Multiple Sclerosis Have More Doctor Visits Decades Before Their Diagnosis
July 18, 2025
Via
Investor Brand Network
Preclinical Study Finds a Way to Reverse Symptoms of Parkinson’s in Mice
July 08, 2025
Via
Investor Brand Network
Clene Inc. (NASDAQ: CLNN) to Conduct Neurofilament Biomarker Analysis for CNM-Au8(R) in ALS in Early Q4 2025
July 07, 2025
Via
Investor Brand Network
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Advances Regulatory Strategy for CNM-Au8 with FDA Meetings Scheduled for ALS and MS Programs
June 30, 2025
Via
Investor Brand Network
Why Public Interest in Mitochondrial Function Testing is Growing
June 26, 2025
Via
Investor Brand Network
Q2 Virtual Investor Summit: Presentations Available Now
June 25, 2025
Via
ACCESS Newswire
12 Health Care Stocks Moving In Monday's After-Market Session
June 16, 2025
Via
Benzinga
Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream
June 13, 2025
Via
Stocktwits
Study Finds Kids with MS Biologically Age Faster Than Those Without It
June 12, 2025
Via
Investor Brand Network
InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) CEO Rob Etherington to Present at June 10 Investor Summit Virtual
June 09, 2025
Via
Investor Brand Network
Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025
June 09, 2025
Via
ACCESS Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.